1. Vascular permeability in chronic rhinosinusitis enhances accumulation and retention of nanoscale pegylated liposomes
- Author
-
Hamidreza Ghandehari, Jolanta Jedrzkiewicz, Nitish Khurana, Jeremiah A. Alt, Amarbir S Gill, Abigail Pulsipher, and Bhuvanesh Yathavan
- Subjects
Pathology ,medicine.medical_specialty ,Chronic rhinosinusitis ,Biomedical Engineering ,Pharmaceutical Science ,Medicine (miscellaneous) ,Bioengineering ,Inflammation ,Vascular permeability ,Polyethylene Glycols ,Capillary Permeability ,Mice ,chemistry.chemical_compound ,Vascularity ,otorhinolaryngologic diseases ,Animals ,Humans ,Medicine ,General Materials Science ,Sinusitis ,Liposome ,business.industry ,chemistry ,Chronic Disease ,Liposomes ,Drug delivery ,Quality of Life ,Molecular Medicine ,medicine.symptom ,Nanocarriers ,business ,Indocyanine green - Abstract
Chronic rhinosinusitis (CRS) is a debilitating inflammatory disorder of the sinonasal mucosa that substantially diminishes patient quality of life. Progress surrounding management of this disease has been crippled by a lack of therapeutic innovation. It has been posited that increased vascularity within the diseased sinuses of patients with CRS may allow for improved systemic drug delivery via nanoscale liposomal carriers. Such a system could enhance drug distribution, accumulation, and retention within the sinuses, ultimately leading to improved patient outcomes. PEGylated liposomes loaded with indocyanine green (ICG) were synthesized, characterized and systemically administered in a mouse model of CRS. Accumulation and retention of ICG in sinonasal tissue were evaluated. Compared to healthy controls, CRS mice showed significant sinonasal tissue accumulation and retention of PEGylated liposomal ICG for up to 21 days (P 0.001). Conversely, free ICG was eliminated from the body after 24 h in both groups.
- Published
- 2021
- Full Text
- View/download PDF